{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To accelerate recovery from acute inflammatory demyelination Patient exhibits disabling neurological deficits requiring urgent intervention\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection against high-dose corticosteroids\n\n*   **Treatment:** Physiotherapy and Occupational Therapy\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To assist with gait rehabilitation and safety due to sensory ataxia and weakness\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires definitive diagnosis (MS vs NMOSD vs MOGAD) via antibody status and CSF results Some MS treatments can exacerbate NMOSD\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To accelerate recovery from acute inflammatory demyelination\", \"Patient exhibits disabling neurological deficits requiring urgent intervention\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection against high-dose corticosteroids\"]}, {\"treatment\": \"Physiotherapy and Occupational Therapy\", \"timing\": \"Start Now\", \"reasons\": [\"To assist with gait rehabilitation and safety due to sensory ataxia and weakness\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires definitive diagnosis (MS vs NMOSD vs MOGAD) via antibody status and CSF results\", \"Some MS treatments can exacerbate NMOSD\"]}]"
}